The primary outcome was MI, and secondary outcomes were the individual ASCVD constituents
By activating GIP receptors, GIP agonists can enhance insulin secretion and lower blood sugar levels
Food and Drug Administration (FDA) announced the launch of its Green List initiative designed to protect consumers from illegally imported GLP-1 drug ingredientssuch as semaglutide and tirzepatideon September 5, 2025
Pills could attract new patients to seek obesity treatment for the first time, expanding the broader weight loss and diabetes drug market and potentially boosting sales for Novo Nordisk and Eli Lilly
Coexpression networks implicate human midfetal deep cortical projection neurons in the pathogenesis of autism
That being said, there are some important points to consider before choosing this treatment: Mild Side Effects : Most patients report temporary redness , swelling , or tenderness at the injection site, which typically resolves within 2448 hours